Rongze Lu

1.5k total citations · 1 hit paper
21 papers, 965 citations indexed

About

Rongze Lu is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Rongze Lu has authored 21 papers receiving a total of 965 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Rongze Lu's work include Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (5 papers) and interferon and immune responses (3 papers). Rongze Lu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immune cells in cancer (5 papers) and interferon and immune responses (3 papers). Rongze Lu collaborates with scholars based in United States, Netherlands and Qatar. Rongze Lu's co-authors include Francesco M. Marincola, Josue Samayoa, Winson S. Ho, Alessandra Cesano, Patrick Danaher, Amy Sullivan, Irena Pekker, Sarah Warren, Brett Wallden and John E. Shively and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Rongze Lu

20 papers receiving 951 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

2018 294 citations Patrick Danaher, Sarah Warren et al. Journal for ImmunoTherapy of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rongze Lu United States	15	380	373	353	189	141	21	965
Jinbiao Chen Australia	20	423 1.1×	622 1.7×	384 1.1×	152 0.8×	139 1.0×	70	1.4k
Melanie Mediavilla-Varela United States	12	270 0.7×	379 1.0×	261 0.7×	119 0.6×	81 0.6×	28	860
Sha Tian United States	16	354 0.9×	682 1.8×	428 1.2×	127 0.7×	243 1.7×	31	1.4k
Lilach Abramovitz Israel	11	376 1.0×	452 1.2×	245 0.7×	105 0.6×	165 1.2×	13	967
Lizhi He Canada	20	344 0.9×	837 2.2×	283 0.8×	176 0.9×	270 1.9×	38	1.4k
Geoffroy Andrieux Germany	18	354 0.9×	665 1.8×	197 0.6×	106 0.6×	184 1.3×	65	1.2k
Palaniswami Rathanaswami Canada	16	252 0.7×	358 1.0×	420 1.2×	234 1.2×	147 1.0×	21	1.2k
Matthew R. Farren United States	19	625 1.6×	396 1.1×	482 1.4×	101 0.5×	195 1.4×	34	1.3k
Deblina Raychaudhuri India	11	461 1.2×	408 1.1×	604 1.7×	132 0.7×	173 1.2×	17	1.2k
Sun-Hwa Kim South Korea	11	347 0.9×	526 1.4×	680 1.9×	96 0.5×	230 1.6×	13	1.3k

Countries citing papers authored by Rongze Lu

Since Specialization

Citations

This map shows the geographic impact of Rongze Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongze Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongze Lu more than expected).

Fields of papers citing papers by Rongze Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongze Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongze Lu. The network helps show where Rongze Lu may publish in the future.

Co-authorship network of co-authors of Rongze Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Rongze Lu. A scholar is included among the top collaborators of Rongze Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongze Lu. Rongze Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Clark, Mary C., Rongze Lu, Winson S. Ho, et al.. (2024). A combination of protein phosphatase 2A inhibition and checkpoint immunotherapy: a perfect storm. Molecular Oncology. 18(10). 2333–2337.

Wu, Zhuhao, Zheng Ao, Hongwei Cai, et al.. (2023). Acoustofluidic assembly of primary tumor-derived organotypic cell clusters for rapid evaluation of cancer immunotherapy. Journal of Nanobiotechnology. 21(1). 40–40. 16 indexed citations

Ho, Winson S., Beisi Xu, Raymond Wai‐Yin Sun, et al.. (2023). PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages. Journal of Clinical Investigation. 133(6). 25 indexed citations

Sun, Raymond Wai‐Yin, Bohyeon Yu, Aarón Díaz, et al.. (2023). PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma. Cancer Research. 83(15). 2527–2542. 29 indexed citations

Huang, Yunpeng, Chenyu Yang, Boxiang Liu, et al.. (2022). Pantothenate kinase 2 interacts with PINK1 to regulate mitochondrial quality control via acetyl-CoA metabolism. Nature Communications. 13(1). 2412–2412. 20 indexed citations

Wu, Zhihao, Winson S. Ho, & Rongze Lu. (2021). Targeting Mitochondrial Oxidative Phosphorylation in Glioblastoma Therapy. NeuroMolecular Medicine. 24(1). 18–22. 34 indexed citations

Lu, Rongze & Winson S. Ho. (2021). Mitochondrial Dysfunction, Macrophage, and Microglia in Brain Cancer. Frontiers in Cell and Developmental Biology. 8. 20 indexed citations

Maggio, Dominic, Winson S. Ho, Stuart Walbridge, et al.. (2020). Inhibition of protein phosphatase-2A with LB-100 enhances antitumor immunity against glioblastoma. Journal of Neuro-Oncology. 148(2). 231–244. 26 indexed citations

Danaher, Patrick, Sarah Warren, Rongze Lu, et al.. (2018). Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA). Journal for ImmunoTherapy of Cancer. 6(1). 63–63. 294 indexed citations breakdown →

10.

Ho, Winson S., Herui Wang, Dominic Maggio, et al.. (2018). Pharmacologic inhibition of protein phosphatase-2A achieves durable immune-mediated antitumor activity when combined with PD-1 blockade. Nature Communications. 9(1). 2126–2126. 60 indexed citations

11.

Turan, Tolga, Maulik Patel, J. Matthew Barnes, et al.. (2018). Immune oncology, immune responsiveness and the theory of everything. Journal for ImmunoTherapy of Cancer. 6(1). 50–50. 46 indexed citations

12.

Ho, Winson S., Saman Sizdahkhani, Shuyu Hao, et al.. (2017). LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Cancer Letters. 415. 217–226. 40 indexed citations

13.

Lu, Rongze, Tolga Turan, Josue Samayoa, & Francesco M. Marincola. (2017). Cancer immune resistance: can theories converge?. Emerging Topics in Life Sciences. 1(5). 411–419. 9 indexed citations

14.

Maggio, Dominic, Winson S. Ho, Herui Wang, et al.. (2017). EXTH-11. PD-1 ANTAGONISM WITH CONCURRENT COMPETITIVE INHIBITION OF PP2A PROMOTES ENHANCED REGRESSION OF INTRACRANIAL GLIOBLASTOMA. Neuro-Oncology. 19(suppl_6). vi75–vi75. 1 indexed citations

15.

Noubade, Rajkumar, Kit Hong Wong, Naruhisa Ota, et al.. (2014). NRROS negatively regulates reactive oxygen species during host defence and autoimmunity. Nature. 509(7499). 235–239. 189 indexed citations

16.

Hong, Xin, Rongze Lu, Heehyoung Lee, et al.. (2013). G-protein-coupled Receptor Agonist BV8/Prokineticin-2 and STAT3 Protein Form a Feed-forward Loop in Both Normal and Malignant Myeloid Cells. Journal of Biological Chemistry. 288(19). 13842–13849. 48 indexed citations

17.

Lu, Rongze, Maciej Kujawski, Hao Pan, & John E. Shively. (2012). Tumor Angiogenesis Mediated by Myeloid Cells Is Negatively Regulated by CEACAM1. Cancer Research. 72(9). 2239–2250. 30 indexed citations

18.

Lu, Rongze, Hao Pan, & John E. Shively. (2012). CEACAM1 Negatively Regulates IL-1β Production in LPS Activated Neutrophils by Recruiting SHP-1 to a SYK-TLR4-CEACAM1 Complex. PLoS Pathogens. 8(4). e1002597–e1002597. 67 indexed citations

19.

Lu, Rongze, Michiel J.M. Niesen, Weidong Hu, Nagarajan Vaidehi, & John E. Shively. (2011). Interaction of Actin with Carcinoembryonic Antigen-related Cell Adhesion Molecule 1 (CEACAM1) Receptor in Liposomes Is Ca2+- and Phospholipid-dependent. Journal of Biological Chemistry. 286(31). 27528–27536. 8 indexed citations

20.

Cusack, James C., et al.. (2006). 179 POSTER EGFR activation and ERK survival signaling is triggered by proteasome inhibitors: Implications for combining proteasome inhibitors with EGFR inhibitors. European Journal of Cancer Supplements. 4(12). 56–56. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact